Health Care
Earnings Preview: Aurinia’s Q4 results pivot on AURORA trial updates
Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH/TSX: AUP) rose 13% on February 25 when the US patent office extended the patent…
Earnings preview Q4: Amyris likely to benefit from the new cannabinoid deal
Renewables product company Amyris (AMRS) is set to report its fourth quarter and full-year 2018 results on Monday, March 18…
Latest FDA approval sends Arcadia Biosciences 23% higher
Shares of Arcadia Biosciences (RKDA) popped 23% during pre-market trading on Friday, after it received approval from the US Food…
Tilray (TLRY) Q4 earnings preview: All you need to know
Tilray (TLRY), which has been trailing other cannabis stocks since the start of this year, will be put under the…
Viking Therapeutics Q4 loss widens on higher expenses but beats estimates
Viking Therapeutics (VKTX) Wednesday posted a wider net loss for the fourth quarter of 2018, owing to a sharp increase…
Q4 Earnings Preview: All eyes on Neutrolin trial updates from CorMedix
Biopharma firm CorMedix (NYSE American: CRMD) has seen its shares skyrocket more than 500% in the last 12 months as…
Aurora Cannabis appoints activist billionaire investor Nelson Peltz as strategic advisor
Aurora Cannabis (ACB) stock surged more than 10% in the pre-market trading as the company appointed activist investor Nelson Peltz…
Cara Therapeutics stock surges after reporting Q4 earnings results
Cara Therapuetics (CARA) reports a loss of $20.7 million or $0.52 per share on revenue of $5.5 million for the…
Avid Bioservices stock jumps after Q3 loss narrows on higher revenues
Avid Bioservices (CDMO) reported a narrower net loss for the third quarter of 2019, aided by a sharp increase in…